Concepedia
Statistics
Publications
37
Citations
4.6K
H-Index
23
Active since
1995
Affiliations
The University of Texas MD Anderson Cancer Center(Current)
University Hospital of Larissa
University of Thessaly
Spanish Oncology Genitourinary Group
Athens Euroclinic
Danai Daliani is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and urology.
Top concepts
MedicineOncologyUrologyPharmacologyCancer TherapyPharmacotherapySurgical OncologyRadiation OncologyPathologyCancer Research
Publications per year
1995–2024
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
Glenn J. Bubley, Michael A. Carducci, William L. Dahut et al. · Journal of Clinical Oncology · 1999 · 979 citations
Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer
Christos N. Papandreou, Danai Daliani, Darrell Nix et al. · Journal of Clinical Oncology · 2004 · 436 citations · Full text
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial
Shi‐Ming Tu, Randall E. Millikan, Bayabel Mengistu et al. · The Lancet · 2001 · 395 citations
Urology, Surgical Oncology, Genitourinary Cancer +8
Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study
Lance C. Pagliaro, Dallas Williams, Danai Daliani et al. · Journal of Clinical Oncology · 2010 · 386 citations · Full text
Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial
Michael A. Carducci, Robert J. Padley, Jürgen Breul et al. · Journal of Clinical Oncology · 2003 · 370 citations
1–5 of 37